Literature DB >> 1429482

Acute tryptophan depletion: a method of studying antidepressant action.

H L Miller1, P L Delgado, R M Salomon, J Licinio, L C Barr, D S Charney.   

Abstract

Serotonin (5-HT) has been implicated in the pathophysiology of depressive syndromes and in the mechanism of antidepressant drug action. Rapid dietary depletion of tryptophan (TRP) provides a paradigm for studying the role of 5-HT in depressed patients. Drug-free depressed patients do not show mood changes during TRP depletion but about one third have a clinically apparent, transient improvement in mood on return to normal TRP intake. Depressed patients in clinical remission after 6 to 8 weeks of antidepressant therapy experience a transient depressive relapse during acute TRP depletion. The significance of these findings will be discussed. Tryptophan depletion in other psychiatric syndromes will also be reviewed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429482

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  The significance of tryptophan in human nutrition.

Authors:  W Heine; M Radke; K D Wutzke
Journal:  Amino Acids       Date:  1995-09       Impact factor: 3.520

2.  Biological and behavioural antidepressant treatment responses with the selective serotonin reuptake inhibitor fluoxetine can be determined by the environment.

Authors:  A W Licinio; M L Wong; J Licinio
Journal:  Mol Psychiatry       Date:  2017-04       Impact factor: 15.992

Review 3.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

Review 4.  Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.

Authors:  Paul R Albert; Laura M Fiori
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin.

Authors:  V Mosienko; B Bert; D Beis; S Matthes; H Fink; M Bader; N Alenina
Journal:  Transl Psychiatry       Date:  2012-05-29       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.